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Abstract 
Among the insidious DNA base lesions, 8-oxo-7,8-dihydroguanine (8-oxoG) is one of the 
most abundant, a lesion that arises through the attack by reactive oxygen species on 
guanine, especially when located in cis-regulatory elements. 8-oxoG is repaired by the 
8-oxoguanine glycosylase 1 (OGG1)–initiated DNA base excision repair pathway.  In 
this study, we investigated whether 8-oxoG repair by OGG1 in promoter regions is 
compatible with a prompt gene expression and a host innate immune response. For this 
purpose, we used a mouse model of airway inflammation, supplemented with cell 
cultures, chromatin immunoprecipitation, small interfering RNA knockdown, real-
time PCR, and comet and reporter transcription assays. Our data show that exposure 
of cells to TNF-α altered cellular redox, increased the 8-oxoG level in DNA, recruited 
OGG1 to promoter sequences, and transiently inhibited base excision repair of 8-
oxoG. Promoter-associated OGG1 then enhanced NF-kB/RelA binding to cis-elements 
and facilitated recruitment of specificity protein 1, transcription initiation factor II-D, 
and p-RNA polymerase II, resulting in the rapid expression of chemokines/cytokines 
and inflammatory cell accumulation in mouse airways. Small interfering RNA 
depletion of OGG1 or prevention  of guanine oxidation significantly decreased  TNF-α–
induced inflammatory responses. Taken together, these results show that 
nonproductive binding of OGG1 to 8-oxoG in promoter sequences could be an 
epigenetic mechanism to modulate gene expression for a prompt innate immune 
response.  
  
 The genomes of living organisms are continuously exposed to reactive oxygen species 
(ROS) derived from the normal metabolism, as well as from pathophysiological processes 
caused by exposure to physical, chemical, or infectious agents. ROS inflict oxidative 
damage on various macromolecules, in- cluding proteins, lipids, and nucleic acids (both 
DNA and RNA) (1). Repair of DNA lesions is crucial for maintaining genomic in- tegrity, 
whereas other oxidatively damaged macromolecules un- dergo degradation (2). One of the 
most abundant oxidized DNA lesions is 8-oxo-7,8-dihydroguanine (8-oxoG), as guanine 
has the lowest oxidation potential among the four bases in DNA (3). The repair of 8-oxoG 
is important because it can mispair with adenine, which results in a G:C to T:A 
transversion during replication, leading to mutations (4). In mammalian cells the 
enzyme cat- alyzing the excision of the 8-oxoG base from the DNA duplex is 8-
oxoguanine DNA glycosylase-1 (OGG1; human and mouse) (5, 6), which is a 
functional analog of the Escherichia coli for- mamidopyrimidine–DNA glycosylase 
protein (5). 
The loss or functional deficiency of OGG1 has been linked to mutagenesis and 
carcinogenesis and is thought to contribute to the aging process and age-associated diseases 
(7, 8). Intriguingly, the supraphysiological levels of 8-oxoG in Ogg1
-/-
 mice do not 
impair embryonic development, and the mice have a normal life span and show no marked 
pathological changes or tumor induction (9–11). Moreover, Ogg1
-/-
  mice are highly 
resistant to inflam- mation induced by ROS, LPS, or allergens. These mice express lower 
levels of proinflammatory chemokines/cytokines (e.g., MIP-1α, TNF-α, IL-4, IL-6, IL-10, 
IL-12, and IL-17), and thus the homing of inflammatory cells to the site of injury is 
decreased (12,13). Our previous work showed that decreased OGG1 expression and 8-oxoG 
 repair in the airway epithelium resulted in a lower allergic inflammatory response after 
ragweed pollen challenge of sensitized mice, as shown by decreased expression of Th2 
cyto- kines, eosinophilia, and airway hyperresponsiveness (14). These results imply that 8-
oxoG base and/or OGG1 could play a key role in proinflammatory gene expression and 
inflammatory processes. It is well documented that transcriptional regulation of proin- 
flammatory genes is highly regulated by ROS-mediated signaling. Previous studies have 
addressed the role of ROS in the posttrans- lational modifications of transcription factors 
(e.g., NF-kB, AP-1) (15–17); however, the possibility that oxidative damage to cis- 
elements may affect the binding of sequence-specific transcription factors and assembly of 
the transcription machinery has attracted less attention. Intriguingly, vertebrate genome 
evolutionarily has a high GC content in the promoter regions of RNA polymerase (Pol) II–
transcribed genes, despite guanine’s vulnerability to be oxidized to the mutagenic 8-oxoG 
and subjected to DNA repair. For instance, a genomic-wide survey revealed that 72% of 
promoters belong to a class with high CpG content (18). Also, the consensus binding sites 
for many transcription factors (e.g., specificity protein 1 [Sp1] and NF-kB) are guanine-rich 
(17, 19). We thus speculate that the high GC content in promoter regions is an advantage 
for tran- scriptional regulation due to nonproductive binding of OGG1 to 8-oxoG under 
conditions of oxidative stress. 
In the present study we show that TNF-α –induced ROS increased 8-oxoG levels in 
the genome, including promoter region(s), and also binding of OGG1 to the CXC motif 
chemokine ligand 2 promoter (mouse and human). Bound OGG1 enhanced Cxcl2 ex- 
pression via facilitating the recruitment of transcription initiation factor II-D (TFIID), NF-
kB/RelA, Sp1, and p-RNA Pol II. OGG1 depletion decreased transcription factor binding 
 to the promoter and TNF-α–mediated innate immune responses (IIRs) in a mouse model of 
airway inflammation. These data strongly suggest a role of OGG1 in transcriptional 
activation of proinflammatory genes in response to oxidative stress. 
 
 
  
 Materials and Methods 
Reagents and Abs 
TNF-α was purchased from PeproTech (Rocky Hill, NJ); N-acetyl-L-cysteine (NAC) Tris, 
NaCl, EDTA, EGTA, Nonidet P-40, sodium pyrophos- phate, glycerophosphate, Na3VO4, 
NaF, aprotin/leupeptin/PMSF, NaDodSO4, and paraformaldehyde were from Sigma-
Aldrich (St Louis, MO). Abs to RelA, Sp1, TFIID, GAPDH, and control IgG were from 
Santa Cruz Bio- technology (Santa Cruz, CA), and Ab to p-RNA Pol II was from Covance 
(Princeton, NJ). Anti-OGG1 and anti-Flag Abs were from Epitomics (Bur- lingame, CA) and 
Sigma-Aldrich, respectively. 
 
Animals, challenge, and evaluation of inflammation 
Six- to 8-wk-old OGG1-proficient or -deficient female BALB/c mice (~20 g; Harlan Sprague 
Dawley, San Diego, CA) were TNF-α challenged intra- nasally with or without antioxidant 
(AO) pretreatment. OGG1 depletion was performed as described below, and AO treatment 
was achieved by i.p. injection of NAC (320 mg/kg) plus ascorbic acid (400 mg/kg) 1 h 
before TNF-α challenge. RNA from the upper one third of lungs was extracted as described 
previously (20). Expression of inflammation-related cytokines and chemokines was 
analyzed by plate-based quantitative PCR arrays (SABiosciences, Valencia, CA) using 
pooled cDNA from each group as template (n = 5). To evaluate inflammation, 
bronchoalveolar lavage fluids (BALF) were collected 16 h after challenge, processed, 
cytospin slides were stained with Wright–Giemsa, and the number of neutrophils was 
counted as we previously described (21). All experiments were performed according to the 
National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. 
 The protocol used was approved by the University of Texas Medical Branch Animal 
Care and Use Committee (no. 0807044A). 
 
Cell cultures 
HEK 293 cells were maintained in DMEM high-glucose medium, and MLE- 12 (an 
immortalized type 2 mouse lung epithelial cell line) was cultured in RPMI 1640 medium, 
per the instructions of the American Type Culture Collection. Ogg1
-/-
 and Ogg1
+/+ mouse 
embryo fibroblasts (MEFs) (10) were provided by Dr. Deborah E. Barnes (Imperial Cancer 
Research Fund, Clare Hall Laboratories, South Mimms, U.K.) and cultured in 
DMEM/Ham’s F-12 medium (22). All media were supplemented with 10% FBS (Atlanta 
Biologicals, Lawrenceville, NJ), penicillin (100 U/ml; Life Technologies- BRL, 
Gaithesburg, MD), and streptomycin (100 µg/ml; Life Technologies- BRL). Cells were 
regularly tested for mycoplasma contamination. 
 
Depletion of OGG1 expression 
To deplete OGG1 from mouse lungs, Stealth RNA interference (RNAi; (Invitrogen Life 
Technologies, Carlsbad, CA, catalog no. MSS237431) was used. Under mild anesthesia, 
parallel groups of mice were treated with Stealth RNAi to Ogg1 (or control RNAi) 
intranasally, and depletion of Ogg1 mRNA in airway epithelial cells was determined by 
real-time PCR (20) using primers purchased from Integrated DNA Technologies (Newark 
NJ, catalog no. Mm.PT.56a.30885470). Small interfering RNA (siRNA) transfection of 
cultured cells was performed using the N-TER nanoparticle transfection system (Sigma-
Aldrich) per the manufacturer’s instructions. siRNA to downregulate mouse Ogg1 
 (catalog no. M-048121-01-005) and human OGG1 (catalog no. M-005147-03-0005) were 
purchased from Dharmacon (Pittsburg, PA). Depletion of the target proteins was 
determined by Western blotting. 
 
RNA extraction and real-time PCR analysis 
RNA was extracted from mouse lungs, HEK 293 cells, and MLE-12 cells using an 
RNeasy kit (Qiagen, Valencia, CA) per the manufacturer’s in- structions. Total RNA (1 
µg) was reverse-transcribed using a SuperScript III first-strand synthesis system (Invitrogen 
Life Technologies). Inflammation- related cytokine and chemokine quantitative PCR arrays 
were analyzed as suggested by the manufacturer (SABiosciences). mRNA levels of indi- 
vidual genes in cultured cells were determined using primers purchased from Integrated 
DNA Technologies: mouse Cxcl2, forward, 5’-CTCCTTTCCAGGTCAGTTAGC-3’, 
reverse, 5’-CAGAAGTCATAGCCACTCTCAA-3’; mouse Gapdh, forward, 5’-
CTCATGACCACAGTCCATGC-3’, reverse, 5’-CACATTGGGGGTAGGAACAC-3’; 
human CXCL2, forward, 5’-CACACTCAAGAATGGGCAGA-3’, reverse, 5’-
CTTCAGGAACAGCCACCAAT-3’; human GAPDH, forward, 5’-
CTGGAGAAACCTGCCAAGTA-3’, reverse, 5’-TGTTGCTGTAGCCGTATTCA-3’. 
Real-time-PCR was performed in an ABI 7000 thermal cycler. Relative expression levels 
of target genes were calculated by the DDCt method as we described pre- viously (20). 
 
Reporter and expression constructs 
The mouse Cxcl2 promoter (-571 to +81) was cloned from the MLE-12 genome and 
inserted into reporter vector pGL4.2 (Promega, Madison, WI) using restriction enzyme 
 sites KpnI and BglII to generate the construct Cxcl2-luciferase (Luc). The proximal Sp1 
binding site (-109 to -100) deletion mutation was designated as Cxcl2-Sp1-del-Luc. The 
inserted DNA was confirmed by sequencing. The plasmid pRL-SV40 encoding Renilla 
luciferase driven by an SV40 promoter (Promega) was used as an internal control. The 
expression plasmid (pcDNA3) encoding IkBa superrepressor (IkBa-SR; resistant to 
phosphorylation by IKK), a mutant form of IkBa (S32A/S36A) was used to block NF-
kB shuttling from the cytoplasm to nucleus. The cDNA of IkBa-SR (~1000 bp) was 
cloned into pcDNA3 at the BamHI restriction site. The pCMV-N-Flag-OGG1 expression 
plasmid encoding N-terminal Flag-tagged human OGG1 was constructed as described in 
our previous report (23). 
 
Transfection and dual reporter luciferase assay 
Transfection was performed using Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instruction. Cells were seeded in 24-well plates and incubated in growth 
medium without antibiotics overnight, then transfected with Cxcl2-Luc (400 ng/well) and 
pRL-SV40–encoding Renilla luciferase (40 ng/well). After 4 h, the medium was replaced 
with complete medium. Twelve hours later, the transfected cells were stimulated with 
TNF-α for various time intervals (0, 1, 3, 6 h) with or without the ROS scavenger NAC, 
and then lysed. Firefly and Renilla luciferase activities were measured using the dual 
luciferase assay system (Promega) with a GloMax microplate luminometer (Promega). 
The transcriptional activity of Cxcl2 was represented by the firefly luciferase activity 
normalized to that of Renilla. 
 
 Coimmunoprecipitation and Western blotting 
HEK 293 cells (1 x 107) were transfected with a Flag-OGG1 expression plasmid, then 
stimulated with TNF-α as described above and lysed in lysis buffer (50 mmol/l Tris [pH 
7.5], 150 mmol/l NaCl, 1 mmol/l EDTA, 1 mmol/l EGTA, 1% Nonidet P-40, 2.5 
mmol/l sodium pyrophosphate, 1 mmol/l glycerophosphate, 1 mmol/l Na3VO4, 1 mmol/l 
NaF, and 20 µg/ml aprotin/leupeptin/PMSF). Cell lysates were centrifuged at 4˚C, 13,000 
x g for 30 min and the supernatants were incubated with 30 µl protein G– Sepharose 
(Millipore, Billerica, MA) at 4˚C for 1 h. The precleared supernatants were incubated 
with Ab against Flag for 12 h and then protein G–Sepharose for 3 h with continuous 
rotation. The immunoprecipitates were then washed with lysis buffer and resolved by 
SDS–PAGE. After the proteins were transferred to nitrocellulose membranes, the 
membranes were washed with TBST (20 mmol/l Tris base, 500 mmol/l NaCl, 0.05% 
Tween 20 [pH 7.5]) and blocked with 10% nonfat dry milk and then incubated for 1 h with 
primary Abs at 1:1000 dilution and subsequently with HRP-conjugated secondary Abs at a 
1:4000 dilution (SouthernBiotech, Birmingham, AL). The signals were detected using the 
ECL Plus chemi- luminescent detection system (GE Life Sciences, Bucking Hampshire, 
U.K.). 
 
Chromatin immunoprecipitation assay 
Chromatin immunoprecipitation (ChIP) assays were performed as described previously (24) 
with slight modifications. Briefly, Flag-OGG1–transfected HEK 293 cells or MEFs 
(Ogg1-/- and Ogg1+/+) were stimulated with TNF-α for 30 min. The cells were 
harvested and the ChIP assays were performed using Abs against Flag or NF-kB/RelA. 
 ChIP reagents were used according to the recommended protocol from Millipore. Cells (1 
x 106) were crosslinked with 1% paraformaldehyde and sheared with 10-s pulses using a 
GEX 130 ultrasonic processor (Cole-Parmer, Vernon Hills, IL) equipped with 2-mm tip and 
set to 30% of maximum power. One milliliter of the 10-fold–diluted reaction mixture was 
incubated with or without Abs and then immunoprecipitated with protein A– or G–agarose 
(Millipore) blocked with salmon sperm DNA. Before adding Abs (Flag, NF-kB/RelA) and 
agarose beads, one tenth of the dilution was directly subjected to DNA extraction and 
used as input. The precipitates were washed extensively with washing buffers, de-
crosslinked, and subjected to regular or real-time PCR. Primers for amplification were: 
human CXCL2 promoter, forward, 5’-ATTCGGGGCAGAAAGAGAAC-3’, reverse, 5’- 
ACCCCTTTTATGCATGGTTG-3’; mouse Cxcl2 promoter, forward, 5’- 
GAAGGGCAGGGCAGTAGAAT-3’, reverse, 5’-TGAAGTGTGGCTGGAGTCTG-3’.  For 
regular PCR analyses, 35 cycles were applied to amplification from ChIP products. 
 
Assessment of intracellular  ROS levels 
Amplex UltraRed (10-acetyl-3,7-dihydroxyphenoxazine; Invitrogen) reagent specifically 
reacts with H2O2 in the presence of HRP to generate a stable product, resorufin. 
Amplex red assays were carried out as we previously described (20) with minor 
modifications. Briefly, after TNF-α addition (0, 5, 10, 15, 25, 30, 60 min) equal numbers of 
cells were washed with PBS (pH 7.4), harvested, and sonicated (3 x 30 s) in reaction 
buffer containing the Amplex UltraRed. Mixtures were incubated for 5 min, cell debris was 
removed (1 min at 13,500 x g), and changes in resorufin fluorescence were determined 
at 560 and 620 nm (excitation and emission, respectively) by using a BioTek FLx800 
 fluorometer. To establish the standard curve, increasing concentrations of H2O2  (0–1000 
nM) were used. Resorufin formation in cell extracts was inhibited by addition of catalase 
(5 U/ml; Sigma-Aldrich). 
 
Assessment of protein cysteine oxidation 
To determine whether OGG1 undergoes redox changes, DCP-Bio1 reagent (KeraFAST, 
Boston, MA) was used. Briefly, cells were transfected with FLAG-OGG1 plasmid, and 
then exposed to TNF-α for 0, 15, 30, 60, and 90 min. Cells were lysed in lysis buffer (50 
mmol/l Tris [pH 7.5], 150 mmol/l NaCl, 1 mmol/l EDTA, 1 mmol/l EGTA, 1% Nonidet P-
40, 2.5 mmol/l sodium pyrophosphate, 1 mmol/l glycerophosphate, 1 mmol/l Na3VO4, 1 
mmol/l NaF, and 20 µg/ml aprotin/leupeptin/PMSF) containing 100 µM DCP-Bio1 (25). 
Cell extracts were clarified and the supernatants were incubated with 30 µl protein G–
Sepharose (Millipore) at 4˚C for 1 h. The precleared supernatants were then incubated with 
Ab against Flag for 12 h and added to protein G–Sepharose for 3 h with continuous 
rotation. The immunoprecipitates were washed with lysis buffer and resolved by SDS-
PAGE. Proteins were transferred to nitrocellulose membranes, blocked with 5% nonfat dry 
milk in TBST for 1 h, and then incubated with streptavidin-conjugated HRP for 1 h. OGG1 
reacted with DCP-Bio1 was detected by ECL. Band intensities were quantitated by 
densitometry using ImageJ (version 1.44) software (National Institutes of Health), and 
percentage changes in levels of oxidative-modified OGG1 was calculated using Microsoft 
Excel. 
 
Protein–protein interaction assays 
 Physical interaction between OGG1 and transacting factors was analyzed as we described 
previously (26). Briefly, Ni-NTA-agarose beads (Qiagen) were incubated with His-
OGG1 protein (6 pmol) (Cytoskeleton) in interaction buffer (50 mM NaH2PO4, 300 mM 
NaCl, 20 mM imidazole, 0.05% Tween 20 [pH 7.5]). After 60 min incubation at 4˚C, 
His-OGG1–bound beads were washed three times, and equimolar, nontagged NF-
kB/RelA (6 pmol; human RelA, Abnova, catalog no. H00005970-P02) was added. To 
elucidate the interaction of OGG1 with Sp1, His-tagged Sp1 (ProteinOne) was used. His-Sp1 
(6 pmol; catalog no. P1034) was added to Ni-NTA for 60 min and washed, and then 
nontagged OGG1 (6 pmol; Cytoskeleton) was added in interaction buffer. After 
incubation for 60 min at 4˚C, samples were washed, proteins were eluted with Laemmli 
buffer (0.125 M Tris- HCl, 4% SDS, 20% glycerol, 10% 2-ME [pH 6.8]) and then 
subjected to SDS-PAGE and analyzed by Western blotting. 
 
Assessment of 8-oxoG level 
8-oxoG in genomic DNA was assessed by determining the levels of OGG1- sensitive sites 
using an OGG1 FLARE comet assay (Travigen, Gaithersburg, MD) (14, 27). Briefly, 
MLE-12 cells with or without TNF-α challenge were embedded in agarose and lysed, 
detergent was removed by washing, and recombinant OGG1 (rOGG1) protein was added 
in the digestion buffer and then the DNA was subjected to alkaline electrophoresis. Fifty 
cells were evaluated for each data point, using the comet assay IV version 4.2 system 
(Perceptive Instruments, Suffolk, U.K.). 
To determine whether TNF-α challenge generates 8-oxoG in the Cxcl2 promoter 
region, MLE-12 cells were challenged with TNF-α for various lengths of time (0, 15, 30, 
 60, and 90 min), and genomic DNA was extracted (QIAamp DNA kit; Qiagen). Genomic 
DNA (20 ng) was subjected to real-time PCR to amplify the proximal region of the 
Cxcl2 promoter, using the primers used in ChIP assays (as described above). 
To examine the 8-oxoG levels in the proximal region of the Cxcl2 pro- moter, 2 µg 
genomic DNA from each sample was incubated with or without rOGG1 (Novus 
Biologicals) in a 100 µl reaction (50 mmol/l Tris-HCl [pH 7.4], 150 mmol/l NaCl, 1 
mmol/l EDTA, 2 mmol/l DTT, 1 mg/ml BSA, and 5 ng rOGG1) at 37˚C for 20 min. 
After digestion, DNA was subjected to phenol/chloroform extraction, and 20 ng DNA 
from each sample was used as a template to amplify the proximal region of the Cxcl2 
promoter as described above. The base excision activity of rOGG1 was determined using 
a 40-mer oligonucleotide containing an 8-oxoG at position 19 and labeled at the 3’ end 
with Cy5 (5’-AGAGAAGAAGAAGAAGAA/8oxodG/AGATGGGTTATTCGAACTAGC 
/3Cy5Sp/-39),  as we previously described (28). 
 
Statistical analysis 
Statistical analysis was performed using a Student t test to analyze changes at the mRNA 
and protein levels. Data from mouse treatment groups were analyzed by ANOVA, 
followed by Bonferroni post hoc analyses for least significant difference. The data are 
presented as the means ± SEM. Differences were considered to be statistically 
significant at p < 0.05. 
 
  
 Results 
OGG1 depletion decreased TNF-α–induced inflammation in mouse lungs  
To address the role of OGG1 in the regulation of proinflammatory genes, mice expressing 
OGG1 (proficient) or depleted in OGG1 (deficient) were challenged intranasally with 
TNF-α. One hour after the challenge, the lungs were excised, RNAs extracted, and 
cDNAs synthesized and subjected to analysis by real-time PCR arrays for cytokine and 
chemokine expression. TNF-α challenge upregulated the expression of inflammatory 
mediators, including CXCLs, CCLs, ILs, and TNF-α. For instance, Cxcl1 mRNA was 
increased 75.9-fold and that for Tnfa 23-fold (Fig. 1A). Unexpectedly, OGG1 depletion 
from the airway epithelium significantly decreased TNF-α –induced proinflammatory gene 
expression. For example, the extent of Cxcl1 and Tnfa mRNA induction decreased to 23.6- 
(by ~70%) and 2.84-fold (by ~90%), respectively, compared with that of OGG1-expressing 
mice (Fig. 1B). Ogg1 mRNA expression in airway epithelial cells was decreased by 85 ± 
6.3% (data not shown) after application of Ogg1 Stealth RNAi, similar to what we have 
shown previously (14). In selected experiments mice were treated with AOs (NAC plus 
ascorbic acid, as described in Materials and Methods). Pretreatment with AOs 
significantly decreased the expression of proinflammatory mediators after TNF-α challenge 
(Fig. 1C), consistent with previous observations (16, 29). AOs alone had no effect on the 
expression of inflammatory medi- ators (data not shown). 
The chemokines CXCL1 and CXCL2 (homologs of human growth-regulated 
protein [Gro] α and β, respectively) are potent attractants of neutrophils, so we further 
examined their mRNA levels by real time RT-PCR using individual primer pairs. The 
results not only confirmed our PCR array data (Fig. 1A), but they showed even higher 
 increases in mRNA levels for CXCL1 (281 ± 73-fold, Fig. 1D, left panel) and CXCL2 
(535 ± 73-fold; Fig. 1D, right panel) in TNF-α –challenged lungs. As expected from the 
robust increase in Cxcl1 and Cxcl2 expression, TNF-α challenge induced extensive 
neutrophilia (>8 x 105  neutrophils/ml BALF) in the lungs. Intriguingly, OGG1 deficiency 
significantly decreased Cxcl1 (by ~74%, Fig. 1D, left panel) and Cxcl2 mRNA levels (by 
~80%, Fig. 1D, right panel), in line with the number of neutrophils in the BALF (Fig. 
1E). Pretreatment of mice with AOs decreased both Cxcl1 and Cxcl2 mRNA levels (Fig. 
1D) and the number of recruited neutrophils in the BALF (Fig. 1E). These results 
suggested that IIR mediated by TNF-α are ROS- and/or OGG1-dependent. 
 
OGG1 augments TNF-α –induced mRNA expression of CXCL2 
To explore the molecular mechanism by which OGG1, a DNA repair enzyme, modulates 
the expression of proinflammatory genes we used a mouse airway epithelial cell (MLE-12) 
model as in our previous studies (16, 29), with Cxcl2 as a representative proin- 
flammatory cytokine gene. Addition of TNF-α (20 ng/ml) to the medium resulted in a 
rapid increase in the level of Cxcl2 mRNA, which reached a maximum (>500 ± 44-fold) 
at 30 min and markedly decreased by 90 min (Fig. 2A). A similar time course of CXCL2 
(Grob) gene expression was observed in HEK 293 cells in response to TNF-α treatment 
(Fig. 2B). Transfection of MLE-12 and HEK 293 cells with siRNA to Ogg1 (or OGG1) 
lowered the increase in Cxcl2 and CXCL2 mRNA levels by ~85 and ~70%, respectively 
(Fig. 2C, 2D), which was proportional to the OGG1 protein levels in siRNA-treated cells 
(Fig. 2E). Moreover, to con- firm OGG1-dependent expression of Cxcl2, we used Ogg1-/- 
and Ogg1+/+ MEFs. Intriguingly, the increase in Cxcl2 mRNA levels after TNF-α 
 exposure was ~8-fold higher in Ogg1+/+ MEFs than in Ogg1+/+ MEFs (Fig. 2F). The ROS 
scavenger NAC significantly decreased the TNF-α –induced increase in Cxcl2 mRNA 
(Fig. 2G, 2H) as well as intracellular ROS levels (Fig. 2I, 2J) levels in both cell types 
after 30 min of exposure, suggesting an essential role of ROS in regulating Cxcl2 and 
GROb gene expression. Our previous work also showed an ROS-dependent increase in 
the proinflammatory cytokines IL-1β and IL-8 at 60 min after TNF-α challenge (16). 
The combined results strongly suggest that ROS generated via TNF-α and OGG1 
expression have crucial roles in upregulation of the proinflammatory gene Cxcl2. 
 
OGG1 is implicated in transcriptional activation from the CXCL2 promoter 
To determine whether OGG1 benefits the expression of CXCL2 via transcriptional 
activation of the CXCL2 promoter, we constructed a reporter plasmid by inserting the 
mouse Cxcl2 promoter (-571 to +81) into the vector pGL4.2. Immediately adjacent to the 
TATA box there are two NF-kB and one Sp1 binding site (Fig. 3A). The proximal Sp1 
binding site deletion mutant was constructed by deleting the consensus nucleotides (-
109 to -100). Time course studies in which we used the luciferase activity assay revealed 
an increase in activation of the Cxcl2 promoter from 1 h on, and >10-fold after 6 h of 
TNF-α treatment (Fig. 3B). No significant increase in luciferase activity was detected in 
HEK 293 cells trans- fected with empty vector plasmid pGL4.2 at any time after the 
addition of TNF-α (data not shown). 
Overexpression of IkB-SR, an NF-kB repressor, decreased Cxcl2 transcription at 6 
h after challenge nearly to the basal level, implying that NF-kB is an essential factor to 
enhance the transcriptional activation of Cxcl2 (Fig. 3C), in line with our previous 
 observations (16). We also examined whether the proximal Sp1 consensus sequence is 
involved in the activation of the Cxcl2 promoter. A dual reporter assay of Cxcl2 promoter 
deleted in its Sp-1 binding site revealed that activation of the mutant Cxcl2 promoter 
reached only ~50% of that of the wild-type promoter in response to TNF-α exposure (Fig. 
3D). These results imply the involvement of Sp1 in the transcriptional activation of Cxcl2. 
To address whether OGG1 is implicated in activation of the Cxcl2 promoter, we 
downregulated OGG1 expression in HEK 293 cells before transfection with reporter 
plasmids. In OGG1-depleted cells TNF-α induced significantly less luciferase activity 
than in control siRNA-transfected HEK 293 cells (Fig. 3E). Treatment with NAC before 
TNF-α addition decreased Cxcl2 promoter activation by ~50% (Fig. 3F), indicating the 
involvement of ROS. These results are in line with those showing a decrease in Cxcl2 
mRNA levels in NAC-treated cells (Fig. 2G, 2H). Taken together, these results imply that 
in response to TNF-α –induced ROS, OGG1 plays a role in the transcriptional activation of 
Cxcl2 driven by NF-kB. 
 
OGG1 binds to CXCL2 promoter and facilitates the recruitment of NF-kB/RelA 
To explore whether OGG1 facilitates Cxcl2 transcription based on its binding to the 
promoter, HEK 293 cells were transfected with a Flag-OGG1 expression plasmid and 
ChIP assays were performed. A 30-min treatment with TNF-α was sufficient to induce an 
impressive increase in the CXCL2 mRNA level; therefore, ChIP assays were carried out at 
30 min after challenge. The results summarized in Fig. 4A show the amplification of the 
282-bp fragment (which is the proximal region of the CXCL2 promoter, containing Sp1 
and NF-kB binding sequences) in the OGG1-associated chromatin precipitate from TNF-α 
 –treated (but not untreated) cells. As a positive control, Ab to NF-kB/RelA also pulled 
down these promoter sequences from cells treated with TNF-α, whereas the negative 
controls (without incubation with Flag or NF-kB/RelA Ab) did not show detectable 
amplification. 
To investigate whether OGG1 expression affects the binding of NF-kB/RelA to the 
CXCL2 promoter region, we used OGG1- depleted HEK 293 cells as well as Ogg1-/- 
and Ogg1+/+ MEF cells. ChIP assays were performed using an NF-kB/RelA Ab. siRNA 
silencing of OGG1 expression decreased the level of NF-kB/RelA associated with the 
CXCL2 promoter in the ChIP product by ~70% compared with that in control siRNA-
transfected HEK 293 cells (Fig. 4B). Additionally, TNF-α treatment induced a <2-fold 
increase in NF-kB/RelA–bound Cxcl2 promoter in Ogg1-/- MEF cells, whereas there was 
a nearly 5-fold increase in NF-kB/RelA pulldown DNA in Ogg1+/+ MEF cells (Fig. 4C). 
Taken together, these data suggest that OGG1 interacts with the promoter and facilitates 
the subsequent recruitment of NF-kB/ RelA. 
 
Binding of OGG1 to 8-oxoG in the Cxcl2 promoter in TNF-α –treated cells is 
nonproductive 
In the human and mouse CXCL2 promoters, Sp1 (GGGGCGGGGC) and NF-kB 
(GGGAATTTCC) binding sites are guanine-rich, which predicts the generation of 8-oxoG 
upon ROS due to TNF-α exposure (Fig. 2I). 8-oxoG is repaired during OGG1–base 
excision repair (BER) (30), and it is conventionally thought that its efficient removal from 
DNA benefits sequence fidelity of promoter and transcription. To investigate this 
possibility, we first performed FLARE comet assays as described in Materials and 
 Methods. As expected, the 8-oxoG levels in TNF-α–treated MLE-12 cells were significantly 
higher than those in untreated cells (Fig. 5A). Fig. 5B shows representative comet moment 
images of DNA with/without rOGG1 (its excision activity is shown in Fig. 5C) digestion 
from cells exposed to TNF-α for 30 min. 
To examine whether 8-oxoG accumulates in the Cxcl2 promoter region, we 
extracted genomic DNA from TNF-α –treated MLE-12 cells at various time points (0, 15, 
30, 60, and 90 min). A 240-bp fragment of the Cxcl2 promoter that contains Sp1 and 
NF-kB binding sites was amplified by real-time PCR. Unexpectedly, the amplifiable 
amount of Cxcl2 promoter was increased after 30 and 60 min of TNF-α treatment (Fig. 
5D) despite the oxidative stress (Fig. 2I). To test whether 8-oxoG is present in the Cxcl2 
promoter, we used rOGG1 protein to release 8-oxoG from genomic DNA. We observed 
that OGG1 digestion significantly decreased the amplifiable amount of Cxcl2 promoter 
sequences (assayed after a 15-, 30-, and 60-min exposure to TNF-α; Fig. 5E) when 
compared to the amount of the Cxcl2 promoter fragment from TNF-α untreated cells. 
Interestingly, after 90 min of TNF-α exposure the amplifiable amount of Cxcl2 promoter 
sequence was similar to that at time 0 (Fig. 5E). NAC treatment before TNF-α addition 
decreased 8-oxoG levels in the DNA and promoter region (data not shown). These results 
imply that 8-oxoG is formed in the proximal region of the Cxcl2 promoter, which was not 
removed by OGG1 in response to TNF-α treatment. To obtain insight into modification of 
OGG1, which could account for its decreased repair activity, we used the DCP-Bio1 
reagent (see Materials and Methods) that specifically reacts with oxidized cysteine 
(sulfenic acid) residues (25). Results in Fig. 5F show that OGG1 oxida- tively modified at 
cysteine residues was the highest at 15 min and then gradually decreased at 30 and 60 min 
 after TNF-α addition. Quantitation of band densities showed that DCP-Bio1–reacting 
OGG1 represent 14.8 ± 4.27% of total OGG1 at 15 min. Its level decreased to 11.2 ± 1.9 
and 9.7 ± 3.22% at 30 and 60 min, respectively, after TNF addition (Fig. 5F, right panel). 
Cysteine modification has been shown to transiently decrease the repair activity of OGG1 
(31, 32), which may explain the observed increase in 8-oxoG level and binding of OGG1 
to the proximal region of the Cxcl2 promoter (Figs. 4A, 5D). These data, combined with 
the ChIP results, suggested that in TNF-α –treated cells, binding of OGG1 to the promoter 
is nonproductive in terms of its 8-oxoG excision activity, as such activity would be expected 
to decrease the amount of fragment amplified, rather than increasing it.  
 
OGG1 interacts with transcription factors in TNF-α–treated cells 
The results from the above studies showed that OGG1 is non-productively bound to 8-oxoG 
in the Cxcl2 promoter in response to TNF-α treatment (Fig. 5A), raising the possibility that 
it interacts with proteins in the transcription complex on the Cxcl2 promoter. To test this 
hypothesis, HEK 293 cells were transfected with Flag-OGG1 expression plasmid, followed 
by treatment with TNF-α, and coimmunoprecipitation assays were performed. The results 
showed that a 15-min TNF-α treatment resulted in increased interactions of OGG1 with 
Sp1, TFIID, and p-RNA Pol II. Interestingly, an increased interaction between OGG1 
and NF-kB/RelA was observed from 30 min on, and it lasted up to 60 min after TNF-α 
addition (Fig. 6A). Given that a 15-min TNF-α challenge was not sufficient to increase 
Cxcl2 mRNA levels (Fig. 3A, 3B), these results imply that NF-kB/RelA is indeed a limiting 
factor for the expression of CXCL2, as shown previously (16, 29). At 90 min after the 
addition of TNF-α, all these transcription factors were markedly decreased in the OGG1-
 associated complex and coin- cided with a low Cxcl2 mRNA level (Fig. 3A, 3B). As 
shown in Fig. 6B, NAC pretreatment significantly lowered the interaction of OGG1 with 
NF-kB/RelA and p-RNA Pol II. 
Next, we explored a possible physical interaction between OGG1 and NF-kB/RelA 
and Sp1. To do so, we carried out protein–protein interactions assays as described in 
Materials and Methods. Results summarized in Fig. 6C and 6D show that OGG1 binds 
both NF-kB/RelA and Sp1. Quantitation of eluted OGG1 and comparison with input NF-
kB indicated a nearly equimolar binding of NF-kB/RelA to OGG1 and OGG1 binding to 
Sp1, suggesting that these transacting factors are directly interacting with OGG1 protein. 
From these results and those showing cysteine oxidation in OGG1 (Fig. 5F), one may 
propose that oxidatively modified OGG1 binds to promoter sequences and interacts with 
transacting factors in TNF-α–exposed cells. To test this hypothesis we examined whether NF-
kB/RelA and/or Sp1 interacts with cysteine sulfenic acid–containing OGG1. To do so, 
Flag-OGG1–expressing cells were exposed to TNF-α, lysed in the presence of DCP-Bio1, 
and coimmunoprecipitation assays were performed using NF-kB/RelA or Sp1 Abs. As 
shown on Fig. 6E and 6F, OGG1 was present both in NF-kB/RelA and Sp1 immune 
complex. More importantly, OGG1 was modified at cysteine (Fig. 6E, 6F) suggesting 
that oxidative modification is required for its physical interactions with transacting 
factors in TNF-α –exposed cells. 
 
 
  
 Discussion 
ROS generated by biological, chemical, and physical agents, as well as ligand–receptor 
interactions or combinations thereof, in- duce cell signaling and modify proteins, lipids, 
and nucleic acids. 8-oxoG is the most common oxidative lesion in DNA because guanine 
has the lowest ionization potential among the DNA bases (1, 4). 8-oxoG preferentially 
accumulates in the guanine-rich ge- nomic regions, including those in the 
enhancer/promoter regions of genes. It is expected that 8-oxoG is repaired to avoid 
mutations and to maintain the sequence fidelity of promoters for efficient binding of 
sequence-specific transcription factors. In this study, we made unexpected discoveries 
suggesting that an association of OGG1 with proximal promoter regions and its 
interaction with Sp1, NF-kB, TFIID, and p-RNA Pol II play a fundamental role in TNF-
α –induced expression of proinflammatory chemo- kines. 
These results are highly unexpected, as OGG1 is thought to be a canonical DNA 
BER enzyme for the removal of 8-oxoG (and Fapy G) owing to its DNA glycosylase–
apurinic/apyrimidinic (AP) lyase activity. The repair activities initiated by OGG1 are 
complex and are modulated by posttranslational modifications, including 
phosphorylation (33) and acetylation (23), as well as by its inter- actions with other repair 
and nonrepair proteins (34). Recent reports also showed that redox changes affecting 
cysteines significantly decrease the activity of OGG1 (31, 32). Binding of OGG1 to 
8-oxoG in promoter regions plays a role in the enhancement of transcription from target 
genes has never been described. 
We have previously documented that TNF-α increases intra- cellular ROS and 
genomic 8-oxoG levels, with a peak increase at 15 min (16, 35). We also showed that 
 TNF-α –induced phosphorylation of NF-kB/RelA at Ser276 (p–NF-kB/RelA) and its 
nuclear translocation are tightly associated with ROS signaling, and that inhibition of 
TNF-α–induced ROS blocks the activities of kinases and decreases NF-kB/p-RelA levels 
(16, 35). Importantly, we showed that p–NF-kB/RelA stable enhanceosome formation 
with p300 and p-RNA Pol II and binding to the IL-8 promoter are ROS-dependent, and that 
the chemically unrelated AOs dimethyl sulfoxide, NAC, and/or vitamin C decreased 
TNF-α –induced IL-8 expression (16, 35, 36). 
In the present study we document that TNF-α induced a robust oxidative stress-
dependent expression of CXCL and CCL proinflammatory mediators and neutrophilia in 
mouse lungs, which was inhibited by AOs (NAC plus ascorbic acid). Intriguingly, the TNF- 
α challenge-induced IIR was nearly prevented by OGG1 depletion in the lung epithelium. 
Likewise, AOs or siRNA to Ogg1 mRNA significantly decreased proinflammatory gene 
expression in cul- tured human and mouse cells. 
TNF-α  has been shown to signal via distinct cell surface receptors TNFR1 and 
TNFR2 (37, 38). For example, upon binding to TNFR1, the liganded receptor aggregates to 
serve as a scaffold to sequentially recruit death domain–containing adaptor proteins, 
TNFR1-associated death domain, TNFR1-associated death domain– associated factor 2, and 
the receptor-interacting protein (39). The activated complex in turn recruits kinases, 
including MAPKs and IkB kinase, and induces ROS for posttranslational modification 
and activation of transcription factors. Therefore, the effects of Ogg1 depletion on the TNF-
α –induced IIR are extremely intrigu- ing, whereas the effect of AOs may be explained by a 
lack of ROS signaling. 
Taking into consideration the similar inhibitory impacts of ROS scavengers shown 
 in the present study and in previous studies (16, 35), the effect of OGG1 depletion on the 
IIR and the lack of known interactions of OGG1 with TNF-α signaling intermediates, we 
speculate that the observed phenomena could be associated with oxidative damage to 
guanines and lack of OGG1 BER of 8-oxoG in the promoter regions. It is documented 
that a large number of promoters driving the transcription of redox-sensitive genes have 
cis-regulatory elements containing runs of guanines (e.g., NF-kB and Sp1 binding sites) 
(17, 19). Thus, it is reasonable to expect that oxidative damage to guanines and BER of 8-
oxoG will hamper the binding of transcription factors to their DNA con- sensus sequences. 
Our results from real-time PCR analysis of the Cxcl2 promoter showed that 8-
oxoG level had increased transiently, suggesting that BER of 8-oxoG did not initiate 
immediately after TNF-α exposure. These data imply that 8-oxoG in the promoter 
region appears not to be an obstacle to the binding of transcription fac- tors. Indeed, 
substitution of the 59 guanine in guanine runs for 8-oxoG has no significant effect on 
Sp1 binding in vitro (40). Another study showed that a 59 8-oxoG in a guanine run 
actually increased NF-kB/p50 binding to its consensus DNA sequence, wheras the 
substitution of later guanines for 8-oxoG decreased p50 binding (41). Binding of Sp1, 
NF-kB, and others to 8-oxoG– containing promoters could have significance, because 
under ox- idative stress conditions in a double helix, containing a p-stacked array of 
heterocyclic bp is favorable for the migration of charge over molecular distance, which 
results in the selective oxidation of 5’ guanine in runs of guanines (42, 43). Alternatively, 
our data strongly suggest that a TNF-α–induced ROS burst leads to oxidation of guanine 
and OGG1 as well as a nonproductive binding of OGG1 to its substrate. Consequently, 
this complex is beneficial for the binding of transcription factors as well as mRNA 
 synthesis. Indeed, OGG1 depletion significantly decreased TNF-α–induced gene 
expression. 
Our ChIP analysis showed that OGG1 binds to the Cxcl2 pro- moter, and it 
appears that its presence is essential for the re- cruitment of transcription factors. To 
prove this point, we show that amplification by real-time PCR from a 240-bp (MLE-12 
cells) and a 282-bp (HEK 293 cells) fragment of the Cxcl2 promoter was increased in 
OGG1-expressing cells after TNF-α addition, compared with amplification of those from 
untreated cells. Our data also showed that TNF-α–induced oxidative stress increases 8- 
oxoG levels in the promoter, as digestion of extracted DNA with rOGG1 before real-time 
PCR significantly decreased amplification from the Cxcl2 promoter. These results imply 
that after TNF-α addition, OGG1 still binds 8-oxoG in the Cxcl2 promoter, but its excision 
activity is inhibited. The mechanism by which BER activity of OGG1 is inhibited is not 
known, but we speculate that TNF-α –induced cellular redox changes may indeed hamper 
OGG1’s 8-oxoG glycosylase/AP lyase activity. In support of this possibility, elegant 
studies showed that oxidation of cysteine residues, of which eight are present in both human 
and mouse OGG1, could be responsible for its decreased 8-oxoG excision activity (31, 32). 
Cysteine sulfenic acid is a well-established oxidative stress-induced modifier of enzymatic 
activities and disulfide bond formation, and it is key in protein folding (44). To obtain 
insight into oxidative modification of OGG1 at cysteines in TNF-α–exposed cells we used 
DCP-Bio1 reagent that specifically reacts with cysteine sulfenic acid (25). We observed that 
a significant portion (~15%) of OGG1 contained cysteine sulfenic acid, suggesting that 
OGG1 bound to 8-oxoG in G-rich promoter sequences is inactivated via cysteine oxidation. 
The direct interaction of OGG1 with trans-acting factors supports our 
 coimmunoprecipitation data and our hypothesis of the role of OGG1 in transcriptional 
initiation of genes. It may thus be suggested that OGG1 nonproductively binds 8- oxoG in 
the promoter sequence under oxidizing conditions such as those induced by TNF-α, and it 
promotes transcriptional activation of proinflammatory genes. The reestablishment of 
normal cellular redox status (by ~90 min, as shown in the present study and in our 
previous studies; Ref. 16) coincided with a sharp decrease in Cxcl2 mRNA levels after 
TNF-α challenge. Therefore, we speculate that OGG1’s glycosylase/AP lyase activity is 
reestablished at this time, and DNA repair intermediates (e.g., AP sites) formed during 
the BER of 8-oxoG in the promoter could be associated with the loss of (defects in) cis-
elements and dislocation of transcription factor and thus termination of transcription. 
Our data also show that OGG1 depletion decreased proinflam- matory mediator 
expression in cultured cells and the IIR in mice after TNF-α challenge. Moreover, TNF-α 
–induced binding of NF-kB/RelA to the Cxcl2 promoter was significantly lower in Ogg1-
/- than in Ogg1+/+ cells, and Sp1, TFIID, and p-RNA Pol II were present in the OGG1 
immunoprecipitation complex. We also show that OGG1 depletion decreased TNF-α –
induced binding of NF-kB/RelA to the Cxcl2 promoter. These results are consistent with 
the finding that we have made by using in vitro binding assays. We found a direct and 
equimolar interaction between OGG1 and NF-kB as well as Sp1, which is in line with 
presence of OGG1 in the immunoprecipitation complex. We furthered these observations by 
showing that NF-kB and Sp1 interact with a glycosylase-inactive cysteine-modified OGG1. 
The significance of these intriguing ob- servations is yet to be revealed, and identification 
of the OGG1 amino acid residues that interact with Sp1 and NF-kB/RelA will be the 
focus of future investigations. 
 Finally, our study identified OGG1-dependent expression of Cxcl2 (the homolog of human 
GROb), which is the most highly expressed among an array of chemokines and cytokines. 
A proposed role of OGG1 in transcriptional initiation of proinflammatory mediators is 
shown in Fig. 7. Expression of CXCL2 may be in- duced by oxidative stress, by chemical 
and physical agents, by viral, bacterial, and fungal infections, or by ligand–receptor 
interactions, and it is chemotactic for polymorphonuclear leukocytes and he- matopoietic 
stem cells. Also, increased expression of CXCL2 is characteristic of senescent cells and 
aged tissues, and it has been associated with chronic inflammatory states such as obesity, 
aging processes, and age-associated diseases, including diabetes (types 1 and 2), Alzheimer 
disease, and others. Moreover, enhanced IL-8 expression has been shown to promote 
cancer progression, and it is a poor prognostic indicator in therapy of a variety of human 
malignancies. All inflammatory processes in acute and chronic diseases are associated 
with an increased oxidative state and formation of 8-oxoG in DNA, especially in guanine-
rich promoters. Although it needs to be proven, we propose that continuous formation of 8-
oxoG and OGG1 binding to promoter sequences could stimulate chronic inflammatory 
processes and could be an epigenetic mechanism to modulate gene expression in response 
to oxidative stress. In support of this hypothesis, mice lacking OGG1 activity show 
increased resistance to inflammation induced by oxidative stress, LPS endotoxins, and 
various allergenic proteins (12, 13). Given the rate-limiting role of OGG1 in the expression 
of CXC chemokines and TNF-α itself, it could be proposed that modulation of OGG1 
activity might be a therapeutic target in the resolution of inflammatory processes that 
impair organ integrity and promote aging processes, as increased OGG1 activity would be 
expected to decrease the expression of proinflammatory genes and recruitment of 
 inflammatory cells. 
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FIGURE 1. Effect of OGG1 on expression of cytokines and chemokines induced by TNF-α . (A) TNF-α 
–induced expression of mRNAs for proin- flammatory mediators. (B) OGG1 deficiency decreases TNF-α 
–induced expression of proinflammatory chemokine and cytokine mRNAs. (C) Effect of AO pretreatment 
on TNF-α –induced expression of proinflammatory mediators. In (A)–(C), groups of mice proficient or 
deficient in expressing OGG1 in the airway epithelium were challenged intranasally with TNF-α . One 
hour later, lungs were excised and RNA was extracted. Pooled cDNA from each group (n = 5) was used as 
a template to perform plate-based inflammation-related PCR arrays. (D) Changes in Cxcl1 (left panel) and 
Cxcl2 (right panel) mRNA levels as determined by real-time PCR in individual lung RNA extracts. OGG1 
depletion and AO pretreatment are described in Materials and Methods. (E) Effect of OGG1 depletion and 
AO on the number of neutrophils in BALF of TNF-α –challenged mice. Mice were TNF-α  treated and 
lavaged at 16 h (see Materials and Methods). The percentage of neutrophils was determined as in 
Materials and Methods (n = 5). *p < 0,05, **p < 0.01, ***p < 0.001. 
  
  
 
FIGURE 2. TNF-α –induced expression of Cxcl2 mRNA is decreased in OGG1-depleted cells. (A and B) 
Time course of Cxcl2 mRNA expression upon TNF-α exposure. MLE-12 (A) and HEK 293 (B) cells 
were TNF-α treated for various lengths of time, RNA was extracted, and real-time PCR was performed. 
(C and D) OGG1 depletion by siRNA lowers the increase in Cxcl2 mRNA levels upon TNF-α treatment. 
OGG1-depleted and control cells [MLE-12 cells in (C), HEK 293 cells in (D)] were exposed to TNF-α for 
30 min, RNA was extracted, and real-time PCR was performed. (E) OGG1 protein levels after siRNA 
silencing of Ogg1. MLE-12 (upper panels) and HEK 293 (lower panels) cells were transfected with siRNA 
to Ogg1, lysed, and Western blot analyses were performed. (F) MEFs lacking OGG1 activity express low 
levels of Cxcl2 mRNA after TNF-α exposure. Ogg1+/+ and Ogg1-/- MEF cells were treated with TNF-α 
for 30 min, RNA was extracted, and real-time PCR was performed. (G and H) The AO pretreatment 
decreases TNF-α – induced expression of the Cxcl2 gene. MLE-12 (G) and HEK 293 (H) cells were 
challenged with TNF-α for 30 min with or without NAC, RNA was extracted, and real-time PCR was 
performed. (I) Kinetic changes in cellular ROS levels in TNF-α –exposed cells as determined by Amplex 
UltraRed assays. (J) NAC pretreatment decreases ROS levels in TNF-α –exposed cells (n = 3-5). **p < 
0.01, ***p < 0.001. 
  
  
 
 
FIGURE 3. OGG1 expression enhances TNF-α –induced activation of the CXCL2 promoter. (A) Diagram 
of the proximal region of the mouse Cxcl2 promoter (containing the TATA box, two NF-kB binding sites, 
and one Sp1 binding site). (B) TNF-α exposure activates the Cxcl2 promoter. HEK 293 cells were 
transfected with a reporter plasmid (Cxcl2-Luc) or control vector (pGL4.2) and then challenged with TNF-
α for the time intervals indicated. Dual reporter assays were performed as in Materials and Methods. (C) 
Activation of the Cxcl2 promoter by TNF-α is inhibited by an NF-kB superrepressor (IkBa-SR). HEK 
293 cells were transfected with the reporter plasmid Cxcl2-Luc with or without overexpression of IkBa-
SR (pcDNA3-IkBa-SR), then challenged with or without TNF-α for 6 h. (D) Deletion of the Sp1 
consensus sequence decreases TNF-α –induced Cxcl2 promoter activation. HEK 293 cells were 
transfected with report plasmids Cxcl2-Luc or Cxcl2-Sp1-del-Luc and then mock or TNF-α challenged 
for 6 h. Luciferase activity in cells without TNF-α challenge was taken as 1. (E) OGG1 depletion inhibits 
TNF-α –induced Cxcl2 promoter activation. HEK 293 cells were transfected with siRNA to OGG1 (or 
control) and transfected with reporter plasmid. After a 12-h recovery, cells were treated with or without 
TNF-α for 6 h. Luciferase activity in cells without TNF-α challenge was taken as 1. (F) AO pretreatment 
decreased TNF-α –induced Cxcl2 promoter activation. HEK 293 cells were transfected with the reporter 
plasmid Cxcl2-Luc, treated with NAC as in Materials and Methods, and then mock or TNF-α challenged 
for 6 h. n = 4–6. **p < 0.01, ***p < 0.001. AV, absolute value; RV, relative value. 
 
  
  
 
 
FIGURE 4. OGG1 binds to the CXCL2 promoter and facilitates NF-kB/RelA recruitment. (A) TNF-α 
increases binding of OGG1 and NF-kB/ RelA to the CXCL2 promoter. HEK 293 cells were transfected with 
Flag- OGG1 plasmid and then treated with or without TNF-α for 30 min. ChIP assays were performed 
using Abs against Flag and NF-kB/RelA. The pulled-down CXCL2 promoter was detected by PCR 
amplification and agarose electrophoresis (amplification from samples without Ab incuba- tion served as 
negative controls). A representative set of experiment is shown out of three. (B) OGG1 depletion decreases 
the association of NF- kB/RelA with the CXCL2 promoter. HEK 293 cells were transfected with siRNA (or 
control siRNA) to OGG1 and then treated with or without TNF-α for 30 min. (C) Lack of OGG1 activity in 
MEFs hampers the binding of NF-kB/RelA to Cxcl2 promoter sequences. Ogg1-/- and Ogg1+/+ MEFs 
were treated with or without TNF-α for 30 min. In (B) and (C), ChIP assay was performed using Ab to NF-
kB/RelA. Quantitative amplification of the CXCL2 promoter from the ChIP products of different cells was 
compared by real-time PCR. Amplification from the ChIP products was normalized to that from input 
genomic DNA, and the value for untreated cells was taken as 1. n = 3–4. **p < 0.01. 
  
  
 
 
FIGURE 5. TNF-α treatment increases the integrity of the Cxcl2 promoter. (A) Accumulation of 8-oxoG in 
genomic DNA in TNF-α –treated cells. MLE-12 cells were challenged with or without TNF-α for 0, 15, 30, 
60, and 90 min. OGG1 FLARE comet assays were performed as in Materials and Methods. (B) 
Representative images show comet moments of DNA with or without rOGG1 digestion (after 30 min of TNF-
α exposure). (C) 8-oxoG excision activity of rOGG1. The activity of OGG1 was determined using Cy5-
labeled 8-oxoG probe (as in Materials and Methods). (D) The amplifiable amount of Cxcl2 promoter is 
increased in response to TNF-α challenge. MLE-12 cells were exposed to TNF-α for time intervals indicated. 
Genomic DNA was extracted and real-time PCR was performed to determine amount of proximal 240-bp-long 
region of Cxcl2 promoter. (E) 8-oxoG accumulates in Cxcl2 promoter. MLE-12 cells were exposed to TNF-α 
as in (A), the extracted DNA was digested with rOGG1, and then a 240-bp-long region of Cxcl2 promoter 
was amplified by real-time PCR. (F) Oxidative modifications at cysteines of OGG1 in TNF-α –exposed cells 
as shown by DCP-Bio1, a sulfenic acid reacting reagent (left upper panel). Right panel shows percentage of 
oxidatively modified OGG1 at cysteines. n = 3–4. *p < 0.05, **p < 0.01, ***p < 0.001. 
  
  
 
 
FIGURE 6. OGG1 interacts with general and site-specific transcription factors. (A) Interactions of OGG1 
with NF-kB/RelA, p-RNA Pol II, Sp1, and TFIID in response to TNF-α challenge. HEK 293 cells were 
transfected with a Flag-OGG1–expressing plasmid and 24 h later cells were treated with TNF-α for the 
indicated time intervals. Coimmunoprecipitation was performed using an Ab against Flag. (B) AO 
decreased the interaction of OGG1 with NF-kB/ RelA and p-RNA Pol II. HEK 293 cells were transfected 
with the Flag-OGG1–expressing plasmid and subjected to TNF-α challenge for 30 min with or without 
NAC pretreatment. Coimmunoprecipitation was performed to analyze the interaction of OGG1 with NF-
kB/RelA and p-RNA Pol II. Shown are representative results of three independent experiments. (C) 
Physical interaction between NF-kB/RelA and OGG1. His-OGG1 was immobilized to NTA- agarose 
beads, washed, and then incubated with equimolar nontagged RelA in interaction buffer for 30 min (see 
Materials and Methods). Bound proteins were eluted and analyzed by Western blotting. (D) Protein–
protein interaction between OGG1 and Sp1. Assays were carried out as in (C) except His-Sp1 was NTA-
agarose immobilized. (E) NF-kB/RelA interacts with oxidatively modified OGG1 at cysteine. Flag-OGG1–
expressing cells were TNF-α exposed and lysed in buffer containing DCP-Bio1. Coimmunoprecipitation 
was performed using Ab to NF-kB/RelA. OGG1 associated with RelA was analyzed for cysteine oxidation 
as in Materials and Methods. (F) Oxidatively modified OGG1 at cysteines interacts with Sp1. Flag-OGG1–
expressing cells were TNF-α exposed and lysed in buffer containing DCP-Bio1. Coimmunoprecipitation 
was performed using Ab to Sp1. OGG1 associated with Sp1 was analyzed for cysteine oxidation as in 
Materials and Methods. n = 3–4. 
  
  
 
 
 
 
FIGURE 7. A model of OGG1-driven transcriptional initiation of proinflammatory mediators. (A) Oxidative 
modification to guanine and OGG1 as well as activation of trans-acting factors by ROS. (B) Nonproductive 
bind- ing of OGG1 to 8-oxoG in promoter region of proin- flammatory genes. (C) Assembly of 
transcriptional ma- chinery facilitated by OGG1. 
 
